The Global Neurovascular Devices Market is accounted for $1.90 billion in 2017 and is expected to reach $4.35 billion by 2026 growing at a CAGR of 9.6% from 2017 to 2026. Some of the key factors influencing the market growth are favorable medical reimbursements, rising target patient population and enhanced effectiveness and better patient outcomes. Moreover, rising number of researches in neurovascular therapies and rising demand for minimally invasive procedures will provide ample opportunities for the growth of the market. However, commercialization across developing economies and lack of skilled neurosurgeons are hampering the market growth.
Neurological devices/Interventional neurology is the non-surgical specialty that uses minimally invasive, image guided techniques for the treatment of most complex and dangerous diseases of neck, brain, and spine. Neurovascular devices are extensively used for the treatment of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others. A variety of material such as nitinol, cobalt, platinum can be used in neurovascular devices to achieve the specialized characteristics for aneurysm repair and ischemic stroke prevention.
By Therapeutic Application, the Ischemic strokes segment is anticipated to grow during the forecast period due to growing patient pool suffering from ischemic stroke. Ischemic stroke occurs when a blood vessel carrying blood to the brain is blocked by a blood clot. By geography, North America has the highest market growth during the forecast period due to high pervasiveness of brain aneurysms. In U.S, High prevalence of ischemic stroke and stenosis will influence the growth.
Some of the key players include Penumbra, Inc., Johnson & Johnson, Microport Scientific Corporation, Abbott Laboratories, Stryker Corporation, Medtronic PLC , Terumo Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Boston Scientific Corporation, LivaNova PLC, Kaneka Medix Corp, Integra Lifesciences, Asahi Intecc CO., LTD, and Integer Holdings Corporation.
Disease Pathologies Covered in this Neurovascular Devices Market are:
End User:
• Ambulatory Surgical Units
• Hospitals
• Clinics
Regions Covered in this Neurovascular Devices Market are:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter\'s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Content Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Neurovascular Devices Market, By Disease Pathology
5.1 Introduction
5.2 Arteriovenous Malformation and Fistulas
5.3 Ischemic Strokes
5.4 Cerebral Aneurysms
5.5 Stenosis
5.6 Other Disease Pathologies
6 Global Neurovascular Devices Market, By Process
6.1 Introduction
6.2 Stenting Technique
6.3 Neurothrombectomy Procedure
6.4 Coiling Procedure Technique
6.5 Cerebral Angiography Technique
6.6 Flow Disruption Technique
8 Global Neurovascular Devices Market, By Therapeutic Application
8.1 Introduction
8.2 Brain Aneurysm
8.3 Therapeutic Application
8.4 Cerebral Artery Stenosis
8.5 Ischemic Strokes
8.6 Hemorrhagic Stroke
8.7 Other Therapeutic Applications
9 Global Neurovascular Devices Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Units
9.3 Hospitals
9.4 Clinics
10 Global Neurovascular Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Penumbra, Inc.
12.2 Johnson & Johnson
12.3 Microport Scientific Corporation
12.4 Abbott Laboratories
12.5 Stryker Corporation
12.6 Medtronic PLC
12.7 Terumo Corporation
12.8 Merit Medical Systems, Inc.
12.9 W.L. Gore & Associates, Inc.
12.10 Boston Scientific Corporation
12.11 LivaNova PLC
12.12 Kaneka Medix Corp
12.13 Integra Lifesciences
12.14 Asahi Intecc CO., LTD
12.15 Integer Holdings Corporation
List of Tables
Table 1 Global Neurovascular Devices Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Neurovascular Devices Market Outlook, By Disease Pathology (2016-2026) ($MN)
Table 3 Global Neurovascular Devices Market Outlook, By Arteriovenous Malformation and Fistulas (2016-2026) ($MN)
Table 4 Global Neurovascular Devices Market Outlook, By Ischemic Strokes (2016-2026) ($MN)
Table 5 Global Neurovascular Devices Market Outlook, By Cerebral Aneurysms (2016-2026) ($MN)
Table 6 Global Neurovascular Devices Market Outlook, By Stenosis (2016-2026) ($MN)
Table 7 Global Neurovascular Devices Market Outlook, By Other Disease Pathologies (2016-2026) ($MN)
Table 8 Global Neurovascular Devices Market Outlook, By Process (2016-2026) ($MN)
Table 9 Global Neurovascular Devices Market Outlook, By Stenting Technique (2016-2026) ($MN)
Table 10 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Procedure (2016-2026) ($MN)
Table 11 Global Neurovascular Devices Market Outlook, By Coiling Procedure Technique (2016-2026) ($MN)
Table 12 Global Neurovascular Devices Market Outlook, By Cerebral Angiography Technique (2016-2026) ($MN)
Table 13 Global Neurovascular Devices Market Outlook, By Flow Disruption Technique (2016-2026) ($MN)
Table 14 Global Neurovascular Devices Market Outlook, By Product (2016-2026) ($MN)
Table 15 Global Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty and Stenting Systems (2016-2026) ($MN)
Table 16 Global Neurovascular Devices Market Outlook, By Embolic Protection Systems (2016-2026) ($MN)
Table 17 Global Neurovascular Devices Market Outlook, By Carotid Artery Stents (2016-2026) ($MN)
Table 18 Global Neurovascular Devices Market Outlook, By Support Devices (2016-2026) ($MN)
Table 19 Global Neurovascular Devices Market Outlook, By Micro Guidewires (2016-2026) ($MN)
Table 20 Global Neurovascular Devices Market Outlook, By Micro Catheters (2016-2026) ($MN)
Table 21 Global Neurovascular Devices Market Outlook, By Aneurysm Coiling & Embolization Devices (2016-2026) ($MN)
Table 22 Global Neurovascular Devices Market Outlook, By Liquid Embolic Agents (2016-2026) ($MN)
Table 23 Global Neurovascular Devices Market Outlook, By Clippings (2016-2026) ($MN)
Table 24 Global Neurovascular Devices Market Outlook, By Embolic Coils (2016-2026) ($MN)
Table 25 Global Neurovascular Devices Market Outlook, By Coil Assist Stent (2016-2026) ($MN)
Table 26 Global Neurovascular Devices Market Outlook, By Coil Assist Balloon (2016-2026) ($MN)
Table 27 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2016-2026) ($MN)
Table 28 Global Neurovascular Devices Market Outlook, By Suction and Aspiration Devices (2016-2026) ($MN)
Table 29 Global Neurovascular Devices Market Outlook, By Clot Retrieval Devices (2016-2026) ($MN)
Table 30 Global Neurovascular Devices Market Outlook, By Snares (2016-2026) ($MN)
Table 31 Global Neurovascular Devices Market Outlook, By Revascularization Devices (2016-2026) ($MN)
Table 32 Global Neurovascular Devices Market Outlook, By Flow Diversion Stents (2016-2026) ($MN)
Table 33 Global Neurovascular Devices Market Outlook, By Carotid Artery Stents (2016-2026) ($MN)
Table 34 Global Neurovascular Devices Market Outlook, By Other Products (2016-2026) ($MN)
Table 35 Global Neurovascular Devices Market Outlook, By Intracranial Stents (2016-2026) ($MN)
Table 36 Global Neurovascular Devices Market Outlook, By Stent Retrievers (2016-2026) ($MN)
Table 37 Global Neurovascular Devices Market Outlook, By Therapeutic Application (2016-2026) ($MN)
Table 38 Global Neurovascular Devices Market Outlook, By Brain Aneurysm (2016-2026) ($MN)
Table 39 Global Neurovascular Devices Market Outlook, By Therapeutic Application (2016-2026) ($MN)
Table 40 Global Neurovascular Devices Market Outlook, By Cerebral Artery Stenosis (2016-2026) ($MN)
Table 41 Global Neurovascular Devices Market Outlook, By Ischemic Strokes (2016-2026) ($MN)
Table 42 Global Neurovascular Devices Market Outlook, By Hemorrhagic Stroke (2016-2026) ($MN)
Table 43 Global Neurovascular Devices Market Outlook, By Other Therapeutic Applications (2016-2026) ($MN)
Table 44 Global Neurovascular Devices Market Outlook, By End User (2016-2026) ($MN)
Table 45 Global Neurovascular Devices Market Outlook, By Ambulatory Surgical Units (2016-2026) ($MN)
Table 46 Global Neurovascular Devices Market Outlook, By Hospitals (2016-2026) ($MN)
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the above manner.
Research Methodology
The Reports Insights offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Reports Insights assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Reports Insights provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
The report is pretty good as a whole. Especially, the analysis on margin and manufacturing cost is challenging to investigate in general. The team of Reports Insights provided a proper explanation to this. It helped me understand the market well, which leads to our interest in the next marketing report from Reports Insights. I would like to thank the entire team for living up to my expectations in terms of quality & value.
I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.
Privacy requested , Managing Director
Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.
Privacy requested, President
Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.
